ENGERIX-B® Hepatitis B Vaccine Indicated for People from Birth Through 19 Years of Age 10 mcg / 0.5 mL Injection Prefilled Syringe 0.5 mL
Menveo® Meningitis Vaccine Indicated for People 2 Months Through 55 Years of Age Meningococcal (Groups A, C, Y, and W-135) Oligosaccharide Diphtheria CRM197 Conjugate Vaccine, Preservative Free 10 mcg - 5 mcg / 0.5 mL Injection Single-Dose Vial 0.5 m
Infanrix® DTaP Vaccine Indicated for People 6 Weeks to 7 Years of Age Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine, Adsorbed Injection Prefilled Syringe 0.5 mL
Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine
NDC Number
Adsorbed
Product Dating
58160081052
Storage Requirements
SLI Medical Acceptable Dating: we will ship >= 180 days
Strength
Requires Refrigeration
Type
25 Lf - 10 Lf - 25 mcg / 0.5 mL
UNSPSC Code
Intramuscular
User
51201631
Volume
Indicated for People 6 Weeks to 7 Years of Age
0.5 mL
Features
INFANRIX is a vaccine indicated for active immunization against diphtheria
tetanus
and pertussis as a 5-dose series in infants and children 6 weeks to 7 years of age
Each 0.5-mL dose is formulated to contain 25 Lf of diphtheria toxoid
10 Lf of tetanus toxoid
25 mcg of inactivated pertussis toxin (PT)
25 mcg of filamentous hemagglutinin (FHA)
and 8 mcg of pertactin (69 kiloDalton outer membrane protein)
Store Refrigerated at 2 to 8 degrees C (36 to 46 degrees F)
Infanrix® DTaP Vaccine Indicated for People 6 Weeks to 7 Years of Age Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine, Adsorbed Injection Prefilled Syringe 0.5 mL
